Skip to main content
logo
BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
55.96
+0.47 (0.85%)
At close: Oct 13, 2025, 4:00 PM EDT
54.50
-1.46 (-2.61%)
After-hours: Oct 13, 2025, 4:53 PM EDT

BridgeBio Pharma Revenue

BridgeBio Pharma had revenue of $110.57M in the quarter ending June 30, 2025, with 4,999.86% growth. This brings the company's revenue in the last twelve months to $235.81M, up 7.62% year-over-year. In the year 2024, BridgeBio Pharma had annual revenue of $221.90M with 2,285.27% growth.

Revenue (ttm)
$235.81M
Revenue Growth
+7.62%
P/S Ratio
44.63
Revenue / Employee
$323,030
Employees
730
Market Cap
10.70B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024221.90M212.60M2,285.27%
Dec 31, 20239.30M-68.35M-88.02%
Dec 31, 202277.65M7.93M11.38%
Dec 31, 202169.72M61.47M745.14%
Dec 31, 20208.25M-32.31M-79.66%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

BBIO News

More News